On Buprenorphine Implants: Should It Be Widely Used For Medically Assisted Treatment?
Buprenorphine implants are recognized as one of the routes to administer Medically Assisted Treatment (MAT). However, the use of these implants is far less compared to oral medications in battling substance abuse. This article explores the likely reasons why buprenorphine implants are not as commonly recommended, and whether it is a feasible option to consider it a mainstream type of treatment.
2. US Food and Drug Administration. FDA approves the first buprenorphine implant for the treatment of opioid dependence. News Release. Silver Spring, MD: FDA. 2016 May 26. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-buprenorphine-implant-treatment-opioid-dependence
3. Food and Drug Administration. Subutex and Suboxone approved to treat opiate dependence. FDA Talk Paper T02-38. Retrieved February. 2002 Oct 8;19:2003. Retrieved from https://www.naabt.org/faq_answers.cfm?ID=2
4. Stewart SA, Domínguez-Robles J, Donnelly RF, Larrañeta E. Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications. Polymers. 2018 Dec;10(12):1379. Retrieved from https://www.mdpi.com/2073-4360/10/12/1379
5. White J, Bell J, Saunders JB, Williamson P, Makowska M, Farquharson A, Beebe KL. Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence. Drug and alcohol dependence. 2009 Jul 1;103(1-2):37-43. Retrieved from Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence
6. Bell JR, Butler B, Lawrance A, Batey R, Salmelainen P. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug and alcohol dependence. 2009 Sep 1;104(1-2):73-7. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S037687160900115X
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).